Manufacturing

Articles

The $3 million investment will go towards various projects investigating key product attributes for therapeutic proteins.

NIIMBL Invests $3 Million in Six Biopharmaceutical Manufacturing Products

The agency received a marketing authorization application a monoclonal antibody treatment for COVID-19 patients.

Application for COVID-19 Treatment Submitted to EMA 

Feliza Mirasol is the science editor for 

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Next-Gen Technologies Tackle Drug Delivery Challenges

Olivia Hughes, olivia.hughes@spherefluidics.com, is a senior marketing associate at Sphere Fluidics.

Growing demand for bispecific antibodies increases the need for automated and miniaturized high throughput screening capabilities.

Using Picodroplet Technology to Optimize Bispecific Cell Lines

Samsung Biologics and Kineta have entered into a strategic partnership for drug product manufacturing services and to support an IND filing of a novel antibody therapeutic. 

Samsung Biologics Partners with Kineta for Anti-VISTA Antibody Immunotherapy

Sparx Therapeutics will build its first commercial manufacturing facility in Yangzhou, China, for antibody drug production.

Sparx Therapeutics to Build Commercial Antibody Manufacturing Facility in China

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Understanding the process and product goals is just the first step to a holistic approach to process development.

Defining a Holistic Approach to mAb Purification Processes

The extended manufacturing agreement between Pinteon and Lonza enables future clinical production of PNT001, a novel Tau antibody therapeutic that targets Alzheimer's disease and traumatic brain injury.

Pinteon and Lonza Extend Collaboration for Manufacturing Antibody Therapeutic

FDA has granted accelerated approval to Biogen for Aduhelm (aducanumab), a new mAb treatment for Alzheimer’ disease.

FDA Grants Accelerated Approval for Biogen’s Alzheimer’s Drug

Avantor plans to increase its single-use manufacturing footprint by 30% and double its cleanroom space in the US and Europe.

Manufacturing, Monoclonal Antibodies